H11.013
Amyloid pterygium of eye, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Amyloid pterygium of the eye is a rare ocular condition characterized by the development of amyloid deposits on the conjunctiva. When it affects both eyes simultaneously, it is referred to as bilateral amyloid pterygium. This condition can influence the appearance and functioning of the eyes, often leading to visual disturbances if left untreated. Understanding the causes, symptoms, and potential management approaches can help in early diagnosis and care.
Causes & Symptoms
Clinical Causes: Genetic predisposition leading to abnormal protein deposition in ocular tissues Chronic ocular surface inflammation or irritation Degenerative changes associated with aging Localized trauma or injury to the eye Certain inherited or systemic conditions linked to amyloid buildup
Key Symptoms: Appearance of a semi-transparent, grayish or yellowish lesion growing from the conjunctiva onto the cornea Visual disturbances, such as blurriness or glare, when the lesion progresses Foreign body sensation in the affected eye(s) Redness or irritation of the conjunctiva Potential for the lesion to enlarge over time, impairing eye function
Diagnostic & Treatment
Diagnosis Path: - Special staining techniques, such as Congo red stain, help in confirming amyloid tissue
Treatment Protocols: - Regular follow-up: Essential for monitoring potential recurrence or progression
Clinical Advice & FAQs
Billing Guidance
Is H11.013 a billable ICD-10 code?
Yes, H11.013 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H11.013?
Clinical documentation must specify the nature of Amyloid pterygium of eye, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference